Abbott Brings Home EUA for COVID-19 Test


Abbott Laboratories, one of the biggest players in the medical device space, has obtained Emergency Use Authorization for a test to detect the coronavirus [COVID-19]. The Abbott Park, IL-based company joins the rapidly expanding list of companies that have received EUA designation in the past few days.
The firm’s RealTime SARS-CoV-2 EUA test can be used on its molecular instrument, the m2000 RealTime System, by authorized laboratories in the U.S.
“Our scientists, many of whom worked on Abbott’s first HIV test and the Zika tests, worked around the clock to develop these molecular tests,” Daman Kowalski, vice president and head of, Molecular Diagnostics at Abbott said in a release. “Providing people at the frontlines of this pandemic with critical tests will help ensure proper care for patients and help protect our communities.”
Abbott will deploy about 150,000 laboratory tests immediately. The firm said it will scale up production at its U.S. manufacturing location to reach capacity for one million tests per week by the end of the month.
While the U.S. has seen an explosion of tests in recent days, it is considered behind other countries in its testing efforts, according to a report from The New York Times.
During a press conference on Wednesday, President Donald Trump announced there would be plans to expand testing in the U.S. noting that several ‘groups’ were working to see if the self-swab test were …

Source: MDDICategory: Medical Devices Authors: Tags: IVD Source Type: news

Related Links:

AbstractAimPrevious studies have discussed association of Fc γRIIA‐R/H131 polymorphism and systemic lupus erythematosus (SLE), lupus nephritis (LN) risk. However, conclusions were inconsistent.MethodsA meta ‐analysis was performed in this study with allelic contrast (allele R vs H), additive model (genotype RR vs HH), recessive model (genotype RR vs RH + HH), and dominant model (genotype RR + RH vs HH).ResultsA total of 33 studies discussed the correlation between Fc γRIIA‐R/H131 polymorphism and SLE, involving 5652 SLE patients and 6322 controls. Allele R was significantly related to SLE in the overall p…

Contributor : Erik ProckoSeries Type : OtherOrganism : Homo sapiensThe rapid and escalating spread of SARS coronavirus 2 (SARS-CoV-2) poses an immediate public health emergency, and no approved therapeutics or vaccines are currently available. The viral spike protein S binds membrane-tethered ACE2 on host cells in the lungs to initiate molecular events that ultimately release the viral genome intracellularly. The extracellular protease domain of ACE2 inhibits cell entry of both SARS and SARS-2 coronaviruses by acting as a soluble decoy for receptor binding sites on S, and is a promising candidate for therapeutic and prophy…

More U.S. states and cities are battling the spread of COVID-19 with school closures, cancelations of public gatherings and businesses limiting services that require human contact.

As new cases of COVID-19 are being confirmed across the globe, here’s what you need to know about the fast-spreading respiratory virus that causes it.

As of March 18, Arizona health officials have confirmed 27 cases and 18 presumptive positive cases of COVID-19. Presumptive positive means tests in Arizona have determined…

In the midst of the COVID-19 pandemic, influenza-related hospitalization rates are the highest on record for children younger than 5 years and adults aged 18 to 49 years, the CDC reports.Medscape Medical News

President Donald Trump’s declaration of a national emergency is designed to speed federal support to parts of America that are struggling to prepare for a coming surge of COVID-19 cases, unlocking $50 billion in aid, giving hospitals and doctors more freedom to handle a potential tsunami of sick patients and scrambling to make tests available. In a Rose Garden press conference Friday, Trump presented the emergency measures as proof that, “No nation is more prepared or more equipped to face down this crisis.”
But for epidemiologists, medical experts and current and former U.S. public health officials, the …

Source: TIME: HealthCategory: Consumer Health News Authors: Tags: Uncategorized COVID-19 Source Type: news

(TOKYO) — The tentacles of canceling the Tokyo Olympics — or postponing or staging it in empty venues — would reach into every corner of the globe, much like the spreading virus that now imperils the opening ceremony on July 24.
The International Olympic Committee and local organizers say the games are on, but the clock is ticking.
The fate of the Tokyo Games touches 11,000 Olympic and 4,400 Paralympic athletes, coaches and sports officials, local organizers, the Japanese government and national morale, international broadcasters, fans and world sponsors. Add to this hotels, airlines and taxi drivers &mda…

Source: TIME: HealthCategory: Consumer Health News Authors: Tags: Uncategorized COVID-19 News Desk wire Source Type: news

TTP, a technology company based in Melbourn, UK, is developing a handheld PCR (polymerase chain reaction) diagnostic device that can rapidly detect influenza viruses, and one day other viruses, in samples of nasal mucus. The company claims that the s…

Source: MedgadgetCategory: Medical Devices Authors: Tags: Diagnostics Exclusive Public Health Source Type: blogs

Source: Aspen Institute. Published: 2/11/2020.
In this one-hour, 22-minute panel discussion, experts with experience in the SARS, Ebola, and Zika outbreaks detail the emerging novel coronavirus (COVID-19) and the threat it poses. They discuss how bad it may get, how dangerous is it, and if the country is prepared for it.
(Video or Multimedia)

Pandemics are perversely democratic. They’re nasty, lethal and sneaky, but they don’t discriminate. No matter your age, ethnicity, religion, gender, or nation, you’re a part of the pathogenic constituency.
That shared vulnerability, and the resulting human collectivism—a universal response to a universal threat—is newly and vividly evident in the face of the now-global outbreak of the novel coronavirus known as 2019-nCoV. As of writing, there have been over 30,000 diagnosed cases and over 630 related deaths. A virus that emerged in a single city, Wuhan, China—indeed, in a single crowded …

Source: TIME: HealthCategory: Consumer Health News Authors: Tags: Uncategorized 2019-nCoV Infectious Disease Source Type: news

“Everyone knows that pestilences have a way of recurring in the world,” observes Albert Camus in his novel The Plague. “Yet somehow we find it hard to believe in ones that crash down on our heads from a blue sky. There have been as many plagues as wars in history; yet plagues and wars always take people by surprise.”
Camus was imagining a fictional outbreak of plague in 1948 in Oran, a port city in northwest Algeria. But at a time when the world is reeling from a very real microbial emergency sparked by the emergence of a novel coronavirus in Wuhan, central China, his observations are as pertinent a…

Source: TIME: HealthCategory: Consumer Health News Authors: Tags: Uncategorized 2019-nCoV health ideas Source Type: news

Source link